Archives

Chartwell Pennsylvania, LP, Affiliated with UPMC d/b/a University of Pittsburgh Medical Center, Joins the Excelera Network to Optimize Specialty Pharmacy and Home Infusion Services 204 115 Shields Health Solutions

Chartwell Pennsylvania, LP, Affiliated with UPMC d/b/a University of Pittsburgh Medical Center, Joins the Excelera Network to Optimize Specialty Pharmacy and Home Infusion Services

MINNEAPOLIS, MN, September 17, 2020 — Chartwell Pennsylvania, LP has partnered with Excelera®, the company behind the Excelera Network, to further optimize its specialty pharmacy and home infusion services, improve…

COVID Jump-Starts Cancer Care at Home 150 150 Shields Health Solutions

COVID Jump-Starts Cancer Care at Home

As the COVID-19 pandemic spread across the country and hospitals reduced in-person visits to a bare minimum, health systems—such as Partners Healthcare, M Health Fairview and Northwestern—worked to ensure that…

ExceleraRx Corp.’s Polan to Present at Fairview Pharmacy Symposium 2020 204 115 Shields Health Solutions

ExceleraRx Corp.’s Polan to Present at Fairview Pharmacy Symposium 2020

MINNEAPOLIS, Sept. 15, 2020 — Excelera®, the company behind the Excelera Network, announced today that Troy Polan, acting CEO and Chief Technology Officer, will present at the Fairview Pharmacy Symposium…

Excelera and Banner Health Collaborate on a Medication Adherence Initiative 1024 629 Shields Health Solutions

Excelera and Banner Health Collaborate on a Medication Adherence Initiative

Last September, Excelera announced its innovative process for assessing medication adherence across its nationwide network of health system specialty pharmacies. The data was presented as a poster at the ASHP Summer…

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center 150 150 Shields Health Solutions

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

By Martha Stutsky, PharmD, BCPS; and Osama Abdelghany, PharmD, MHA, BCOP Smilow Cancer Hospital at Yale New Haven Health System in Connecticut is 1 of 45 National Cancer Institute–designated comprehensive…

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective 150 150 Shields Health Solutions

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

By Claudia S. Castro, PharmD, MS, BCOP, BCGP; and Amanda Manoogian, PharmD, BCOP The prevalence of individuals living with cancer continues to rise, largely because of an aging and growing…

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit 204 115 Shields Health Solutions

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit

Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Complex Patient Data Platform Drives Business Intelligence 1024 576 Shields Health Solutions

Complex Patient Data Platform Drives Business Intelligence

By Troy Polan, Acting CEO and CTO Sophisticated data capabilities set Excelera apart. Our Complex Patient Data Platform supports dashboards of critical as well as supplementary data for each health…

COVID & Oncology – The Effects on Health System Specialty Pharmacies 1024 791 Shields Health Solutions

COVID & Oncology – The Effects on Health System Specialty Pharmacies

This blog was written by Excelera, a Shields company. Two months ago, our blog discussed the potential impacts and areas of concern for health system specialty pharmacies and COVID. However,…

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network 204 115 Shields Health Solutions

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network

Orlando Health is the first health system in Florida to partner with Excelera®, the company behind the Excelera Network, to further optimize its specialty pharmacy services and to provide patients with increased access to limited distribution drugs (LDDs), which include innovative oncology treatments.